FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study finds that AI is better at forecasting the risk of developing cancer.

2.

Similar survival seen with simple versus radical hysterectomy for cervical cancer

3.

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

4.

Cancer cells with thick glycocalyx barrier evade immune system better: study

5.

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot